CardioLogs ECG Analysis Platform vs Zio ECG Utilization Software (ZEUS) System

Direct competitors — feature-level head-to-head below. Comparability 88/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cardiologs Technologies (now part of Philips)
VS
by iRhythm Technologies

AI Verdict

Tool A and Tool B are direct competitors, both offering AI-powered, cloud-based ECG analysis platforms for arrhythmia detection and diagnosis. While Tool A emphasizes multi-device compatibility for ECG data input, Tool B is specifically integrated with its proprietary Zio wearable monitors. The selection between them would depend on a healthcare provider's existing monitoring infrastructure and preference for an integrated hardware-software solution versus a more flexible analysis platform.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your practice utilizes a variety of cardiac monitoring devices, including Holter monitors, smartwatches, and ECG patches, and you require a single, AI-powered platform for rapid and accurate analysis across all of them. This solution is ideal for healthcare providers seeking flexible integration with existing hardware and customizable reporting for diverse patient populations.

View CardioLogs ECG Analysis Platform →

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose Zio ECG Utilization Software (ZEUS) System if your practice primarily leverages iRhythm's Zio wearable monitors for continuous, long-term ECG data collection. This integrated platform offers proprietary deep-learned algorithms specifically optimized for Zio biosensors, providing comprehensive end-of-wear reports and a streamlined workflow within the Zio ecosystem.

View Zio ECG Utilization Software (ZEUS) System →

When choosing between the Cardiologs ECG Analysis Platform and the Zio ECG Utilization Software (ZEUS) System, physicians should consider their existing workflow and the types of devices they utilize. Cardiologs excels in its versatility, offering AI-powered analysis for ECG data from a wide array of cardiac monitoring devices, including Holter monitors, smartwatches, and various ECG patches. This makes it ideal for practices that employ a diverse range of monitoring equipment and seek a centralized, device-agnostic analysis solution. Its ‘pay per ECG’ model may also be attractive for practices with fluctuating volumes or those looking to avoid per-user licensing.

In contrast, the Zio ECG Utilization Software (ZEUS) System is specifically designed to integrate with iRhythm’s proprietary Zio wearable biosensors, such as the Zio monitor and Zio Watch. This tight integration allows for continuous ECG data analysis for extended periods (up to 14 days) and provides comprehensive end-of-wear reports. ZEUS is best suited for physicians who primarily utilize or plan to adopt the Zio ecosystem for long-term, continuous cardiac monitoring. The key practical difference lies in their ecosystem compatibility: Cardiologs offers broad device compatibility, while ZEUS provides a deeply integrated solution within the Zio monitoring platform.

Therefore, a physician with a varied inventory of ECG devices and a need for flexible, centralized analysis would likely find Cardiologs more suitable. Conversely, a physician committed to the Zio wearable monitoring system and seeking a seamless, integrated analysis platform for extended monitoring would benefit more from the Zio ECG Utilization Software (ZEUS) System.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform Zio ECG Utilization Software (ZEUS) System
Pricing Contact sales for customized quote Contact for pricing
Deployment Cloud-based (SaaS) Cloud-based (AWS EC2 platform)
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio ECG Utilization Software (ZEUS) System

While both offer cloud-based platforms and EHR integration, Tool B's explicit mention of a mobile application for healthcare professionals and its deep integration with Epic Aura, which significantly streamlines workflows and enhances patient experience via MyChart, gives it an edge in overall usability for both clinicians and patients. The Zio monitor's 'peel and stick' design also contributes to high patient compliance and ease of use.

Clinical Value

Zio ECG Utilization Software (ZEUS) System

Both tools demonstrate strong clinical value with FDA clearance and AI-powered analysis. However, Tool B has extensive clinical evidence highlighting its superior diagnostic yield, lower retesting rates, and high physician agreement with its reports, particularly in long-term continuous monitoring. Its AI algorithm is clinically proven to perform at the level of cardiologists.

Pricing & Value

CardioLogs ECG Analysis Platform

Tool A provides a clearer pricing model ('Pay per ECG'), offering a degree of transparency that Tool B lacks, as Tool B's pricing details are not publicly available. While both require contacting sales for a quote, knowing the billing unit for Tool A allows for better initial value assessment. [cite: JSON]

Enterprise Readiness

Zio ECG Utilization Software (ZEUS) System

Both are strong contenders, being cloud-based, HIPAA compliant, and offering EHR integration. However, Tool B's specific collaboration with Epic Aura for streamlined integration and workflow optimization for large health systems demonstrates a higher level of enterprise readiness and tailored solutions for major healthcare providers.

Innovation

Tie

Both tools demonstrate significant innovation. Tool A was a pioneer in FDA-cleared AI for ECG analysis and offers broad device compatibility and predictive capabilities. Tool B excels with its integrated wearable biosensor ecosystem, long-term continuous monitoring, and strategic EHR integration, earning awards for its innovative approach to cardiac monitoring.

Support & Docs

Tie

Both companies provide clear avenues for support, including online portals, contact information, and product documentation. While Tool A is backed by Philips' broader support infrastructure, Tool B offers specific customer care contacts and detailed instructions for use for its integrated system, making them comparably strong in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform Zio ECG Utilization Software (ZEUS) System
Name CardioLogs ECG Analysis Platform Zio ECG Utilization Software (ZEUS) System
Company Cardiologs Technologies (now part of Philips) iRhythm Technologies
Tagline Reinventing cardiology diagnostics with medical-grade AI and cloud technology. Innovating the Future of Cardiac Monitoring
Key Features (AI/Analysis) AI-Powered ECG Analysis (Deep Neural Networks), Automated Arrhythmia Detection (e.g., AFib, VT) AI algorithm for arrhythmia detection and classification, Proprietary deep-learned algorithms for enhanced diagnostic accuracy
Key Features (Compatibility/Integration) Multi-Device Compatibility (Holter, smartwatches, ECG patches), Integration with EHR Systems Integration with Zio wearable biosensors (Zio monitor, Zio Watch), HL7-based EHR integration
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and Zio ECG Utilization Software (ZEUS) System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CardioLogs ECG Analysis Platform is designed for multi-device compatibility, supporting ECG data from various cardiac monitoring devices such as Holter monitors, smartwatches, ECG patches, event recorders, and 12-lead ambulatory ECG devices. In contrast, the Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data specifically from iRhythm's proprietary wearable Zio monitors, including the Zio monitor and Zio Watch.
The CardioLogs platform provides AI-powered ECG analysis and supports real-time monitoring/analysis of various ECG data, including long-term ambulatory ECG recordings. The Zio ECG Utilization Software (ZEUS) System is specifically designed for continuous ECG data analysis for up to 14 days from its wearable Zio monitors.
Both platforms offer integration with EHR systems. CardioLogs states integration with EHR systems, and can be electronically interfaced with other computer-based ECG systems. The Zio ECG Utilization Software (ZEUS) System specifies HL7-based EHR integration.
The CardioLogs ECG Analysis Platform features real-time monitoring/analysis capabilities in addition to analyzing recordings. The Zio ECG Utilization Software (ZEUS) System primarily provides comprehensive end-of-wear reports for physician review after continuous ECG data analysis, with preliminary findings available during wear for some Zio AT services.
CardioLogs utilizes deep neural networks and medical-grade AI, built upon over 200 million recordings, to analyze ECG waveforms for arrhythmia detection, with studies showing improved specificity and reduced false positives for AFib detection compared to traditional methods. The Zio ECG Utilization Software (ZEUS) System employs proprietary deep-learned AI algorithms, clinically proven to perform at the level of cardiologists, for arrhythmia detection and classification, with end-of-wear reports demonstrating 99% physician agreement.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.